The biotech industry needs to stop waiting for a rebound. The pandemic changed everything, though not in the ways most people ...

That’s not for lack of opportunity. Japan’s scientists continue to produce Nobel Prize–winning breakthroughs and the country ...

Healthcare investor Kevin Tang and his allies now hold almost every leadership position at Aurinia Pharmaceuticals, the ...

The multivalent candidate, being developed by Pfizer and French partner Valneva under a 2020 pact, generated higher than 73% ...

The FDA detected 14 cases of vitamin B6 deficiency–linked seizures and two deaths in patients with Parkinson’s disease taking ...

Earendil Labs’ AI-centered platform has produced more than 40 programs, including anti-inflammatory assets that have attracted a pair of partnership agreements with Sanofi.

Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with ...

Longevity is a long-standing buzzword in life sciences, but it now has staying power. The smart trajectory is to stop chasing ...

As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and ...

Eli Lilly and Regeneron are leading the push to treat congenital deafness with gene therapies, seeking a piece of a potential ...

The FDA’s Commissioner’s National Priority Voucher program, unveiled in June 2025, is “shrouded in secrecy,” Democratic ...

A spokesperson for the Department of Health and Human Services refuted the claim, made Thursday on social media by ACIP Vice ...